• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菌株对所选病原体黏附特性的拮抗活性。

Antagonistic Activity of Strains on the Adhesion Characteristics of Selected Pathogens.

作者信息

Singh Tejinder P, Kaur Gurpreet, Kapila Suman, Malik Ravinder K

机构信息

Dairy Microbiology Division, National Dairy Research Institute Karnal, India.

Animal Biochemistry Division, National Dairy Research Institute Karnal, India.

出版信息

Front Microbiol. 2017 Mar 21;8:486. doi: 10.3389/fmicb.2017.00486. eCollection 2017.

DOI:10.3389/fmicb.2017.00486
PMID:28377765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5359300/
Abstract

Adhesion ability of probiotics is the key factor that decides their colonization in the gastrointestinal tract and potential to inhibit pathogens. Therefore, adhesion ability can be considered as a key determinant for probiotic efficacy. Presents study documents the antagonistic activity of viable/untreated, Lithium chloride (LiCl) treated or heat-killed forms of eight probiotic strains on the adhesion characteristics of selected pathogens. All strains investigated were able to adhere to Caco-2 cells. strains tested were able to inhibit and displace ( < 0.05) the adhesion of ATCC25922, NCDC113, ATCC53135, and NCDC115. The probiotic strain LR6 showed the strongest adhesion and pathogen inhibition ability among the eight strains tested. In addition, the abilities to inhibit and to displace adhered pathogens depended on both the probiotic and the pathogen strains tested suggesting the involvement of various mechanisms. The adhesion and antagonistic potential of the probiotic strains were significantly decreased upon exposure to 5 M LiCl, showing that surface molecules, proteinaceous in nature, are involved. The heat-killed forms of the probiotic strains also inhibited the attachment of selected pathogens to Caco-2 cells. In conclusion, assays showed that strains, as viable or heat-killed forms, are adherent to Caco-2 cells and are highly antagonistic to pathogens tested in which surface associated proteins play an important role.

摘要

益生菌的黏附能力是决定其在胃肠道定殖及抑制病原体潜力的关键因素。因此,黏附能力可被视为益生菌功效的关键决定因素。本研究记录了8种益生菌菌株的活/未处理、经氯化锂(LiCl)处理或热灭活形式对所选病原体黏附特性的拮抗活性。所有研究的菌株都能够黏附于Caco-2细胞。所测试的菌株能够抑制并取代(<0.05)ATCC25922、NCDC113、ATCC53135和NCDC115的黏附。益生菌菌株LR6在所测试的8种菌株中表现出最强的黏附及病原体抑制能力。此外,抑制和取代已黏附病原体的能力取决于所测试的益生菌和病原体菌株,这表明涉及多种机制。经5 M LiCl处理后,益生菌菌株的黏附及拮抗潜力显著降低,表明参与其中的是本质为蛋白质的表面分子。益生菌菌株的热灭活形式也抑制了所选病原体对Caco-2细胞的附着。总之,试验表明,无论是活的还是热灭活形式的菌株,都能黏附于Caco-2细胞,并且对所测试的病原体具有高度拮抗作用,其中表面相关蛋白起着重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd31/5359300/563a135474ee/fmicb-08-00486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd31/5359300/563a135474ee/fmicb-08-00486-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd31/5359300/563a135474ee/fmicb-08-00486-g001.jpg

相似文献

1
Antagonistic Activity of Strains on the Adhesion Characteristics of Selected Pathogens.菌株对所选病原体黏附特性的拮抗活性。
Front Microbiol. 2017 Mar 21;8:486. doi: 10.3389/fmicb.2017.00486. eCollection 2017.
2
In vitro characterization of aggregation and adhesion properties of viable and heat-killed forms of two probiotic Lactobacillus strains and interaction with foodborne zoonotic bacteria, especially Campylobacter jejuni.体外鉴定两种益生菌乳杆菌活菌和热死菌的聚集和黏附特性及其与食源性病原体细菌,特别是空肠弯曲菌的相互作用。
J Med Microbiol. 2013 Apr;62(Pt 4):637-649. doi: 10.1099/jmm.0.049965-0. Epub 2013 Jan 17.
3
Growth and adhesion inhibition of pathogenic bacteria by live and heat-killed food-origin Lactobacillus strains or their supernatants.活菌和热灭活食品来源乳酸菌株或其上清液对病原菌的生长和黏附抑制作用。
FEMS Microbiol Lett. 2021 Apr 8;368(5). doi: 10.1093/femsle/fnab024.
4
Anti-adhesion of probiotic Enterococcus faecium WEFA23 against five pathogens and the beneficial effect of its S-layer proteins against Listeria monocytogenes.益生菌屎肠球菌WEFA23对五种病原体的抗黏附作用及其表层蛋白对单核细胞增生李斯特菌的有益作用。
Can J Microbiol. 2019 Mar;65(3):175-184. doi: 10.1139/cjm-2018-0031. Epub 2018 Nov 5.
5
Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage.从母乳喂养婴儿的粪便和台湾酸菜中分离出的乳酸菌的益生菌特性。
Anaerobe. 2010 Dec;16(6):578-85. doi: 10.1016/j.anaerobe.2010.10.003. Epub 2010 Oct 15.
6
Assessment of probiotic adhesion and inhibitory effect on Escherichia coli and Salmonella adhesion.评估益生菌对大肠杆菌和沙门氏菌黏附的抑制效果。
Arch Microbiol. 2021 Dec;203(10):6267-6274. doi: 10.1007/s00203-021-02593-z. Epub 2021 Sep 28.
7
Cell surface and extracellular proteins of potentially probiotic Lactobacillus reuteri as an effective mediator to regulate intestinal epithelial barrier function.潜在益生菌罗伊氏乳杆菌的细胞表面和细胞外蛋白作为有效调节剂,调节肠道上皮屏障功能。
Arch Microbiol. 2021 Aug;203(6):3219-3228. doi: 10.1007/s00203-021-02318-2. Epub 2021 Apr 8.
8
Adhesive ability means inhibition activities for lactobacillus against pathogens and S-layer protein plays an important role in adhesion.黏附能力是指乳酸菌对病原体的抑制活性,而 S-层蛋白在黏附中起着重要作用。
Anaerobe. 2013 Aug;22:97-103. doi: 10.1016/j.anaerobe.2013.06.005. Epub 2013 Jun 21.
9
A Systematic Approach to Identify and Characterize the Effectiveness and Safety of Novel Probiotic Strains to Control Foodborne Pathogens.一种识别和表征新型益生菌菌株控制食源性病原体有效性和安全性的系统方法。
Front Microbiol. 2019 May 17;10:1108. doi: 10.3389/fmicb.2019.01108. eCollection 2019.
10
Characterization of Intestinal Lactobacillus reuteri Strains as Potential Probiotics.作为潜在益生菌的肠道罗伊氏乳杆菌菌株的特性分析
Probiotics Antimicrob Proteins. 2012 Mar;4(1):47-58. doi: 10.1007/s12602-012-9090-2.

引用本文的文献

1
Functional and Safety Profile of and Development of Oral Fast-Disintegrating Tablets for Gut Microbiota Modulation.用于调节肠道微生物群的口腔速崩片的功能与安全性概况及研发
Pharmaceutics. 2025 Aug 1;17(8):1011. doi: 10.3390/pharmaceutics17081011.
2
A Fungistatic Strategy Using a Shear-Thinning pH-Responsive CMCS-OHA-Lp/Lr Hydrogel for Vulvovaginal Candidiasis.一种使用剪切变稀pH响应性壳聚糖-油酸-卵磷脂/脂质体水凝胶治疗外阴阴道念珠菌病的抑菌策略。
Pharmaceutics. 2025 Apr 17;17(4):527. doi: 10.3390/pharmaceutics17040527.
3
Probiotic, Paraprobiotic, and Postbiotic Activities of KUNN19-2 Against Non-Typhoidal Serovars.

本文引用的文献

1
Characterization of Intestinal Lactobacillus reuteri Strains as Potential Probiotics.作为潜在益生菌的肠道罗伊氏乳杆菌菌株的特性分析
Probiotics Antimicrob Proteins. 2012 Mar;4(1):47-58. doi: 10.1007/s12602-012-9090-2.
2
Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches.发现益生菌微生物:体外、体内、遗传和组学方法。
Front Microbiol. 2015 Feb 17;6:58. doi: 10.3389/fmicb.2015.00058. eCollection 2015.
3
Adhesive ability means inhibition activities for lactobacillus against pathogens and S-layer protein plays an important role in adhesion.
KUNN19-2对非伤寒血清型的益生菌、副益生菌和后生元活性
Int J Mol Sci. 2025 Feb 20;26(5):1821. doi: 10.3390/ijms26051821.
4
Safety, Antagonistic Activity, and Probiotic Properties of Lactic Acid Bacteria Isolated from Jeotgal, Korean Fermented Seafoods.从韩国发酵海鲜盐渍物中分离出的乳酸菌的安全性、拮抗活性及益生菌特性
J Microbiol Biotechnol. 2024 Dec 13;35:e2411055. doi: 10.4014/jmb.2411.11055.
5
subsp. HN019 live probiotics and postbiotics: production strategies and bioactivity evaluation for potential therapeutic properties.亚种HN019活益生菌和后生元:潜在治疗特性的生产策略及生物活性评估
Front Bioeng Biotechnol. 2024 Jul 9;12:1379574. doi: 10.3389/fbioe.2024.1379574. eCollection 2024.
6
Heat-killed Limosilactobacillus reuteri ATCC PTA 6475 prevents bone loss in ovariectomized mice: A preliminary study.热灭活罗伊氏乳杆菌 ATCC PTA 6475 可预防去卵巢小鼠的骨丢失:初步研究。
PLoS One. 2024 May 31;19(5):e0304358. doi: 10.1371/journal.pone.0304358. eCollection 2024.
7
Probiotic Properties of Strains Isolated from Natural Whey Starter Cultures.从天然乳清发酵剂培养物中分离出的菌株的益生菌特性。
Foods. 2024 Mar 21;13(6):957. doi: 10.3390/foods13060957.
8
Biotics and Children's and Adolescents' Health: A Narrative Review.生物制剂与儿童及青少年健康:一篇叙述性综述
Children (Basel). 2024 Mar 9;11(3):329. doi: 10.3390/children11030329.
9
How probiotics, prebiotics, synbiotics, and postbiotics prevent dental caries: an oral microbiota perspective.益生菌、益生元、合生元和后生元如何预防龋齿:口腔微生物组视角。
NPJ Biofilms Microbiomes. 2024 Feb 24;10(1):14. doi: 10.1038/s41522-024-00488-7.
10
Postbiotics: Functional Food Materials and Therapeutic Agents for Cancer, Diabetes, and Inflammatory Diseases.后生元:用于癌症、糖尿病和炎症性疾病的功能性食品原料及治疗剂
Foods. 2023 Dec 26;13(1):89. doi: 10.3390/foods13010089.
黏附能力是指乳酸菌对病原体的抑制活性,而 S-层蛋白在黏附中起着重要作用。
Anaerobe. 2013 Aug;22:97-103. doi: 10.1016/j.anaerobe.2013.06.005. Epub 2013 Jun 21.
4
In vitro characterization of aggregation and adhesion properties of viable and heat-killed forms of two probiotic Lactobacillus strains and interaction with foodborne zoonotic bacteria, especially Campylobacter jejuni.体外鉴定两种益生菌乳杆菌活菌和热死菌的聚集和黏附特性及其与食源性病原体细菌,特别是空肠弯曲菌的相互作用。
J Med Microbiol. 2013 Apr;62(Pt 4):637-649. doi: 10.1099/jmm.0.049965-0. Epub 2013 Jan 17.
5
Lactobacillus adhesion to mucus.乳酸菌黏附于黏液。
Nutrients. 2011 May;3(5):613-36. doi: 10.3390/nu3050613. Epub 2011 May 20.
6
Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells.评估疑似本土益生菌乳杆菌与人结肠上皮细胞的黏附性。
Indian J Med Res. 2011 Nov;134(5):664-71. doi: 10.4103/0971-5916.90992.
7
Characterization of the insoluble proteome of Lactococcus lactis by SDS-PAGE LC-MS/MS leads to the identification of new markers of adaptation of the bacteria to the mouse digestive tract.通过 SDS-PAGE LC-MS/MS 对乳球菌不可溶性蛋白质组进行分析,鉴定出细菌适应小鼠消化道的新的适应标志。
J Proteome Res. 2010 Feb 5;9(2):677-88. doi: 10.1021/pr9000866.
8
Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells.特定菌株益生菌(瑞士乳杆菌)对空肠弯曲菌侵袭人肠上皮细胞的抑制作用。
FEMS Microbiol Lett. 2009 Nov;300(1):146-52. doi: 10.1111/j.1574-6968.2009.01781.x. Epub 2009 Sep 4.
9
Effects of probiotic Lactobacillus salivarius W24 on the compositional stability of oral microbial communities.益生菌唾液乳杆菌W24对口腔微生物群落组成稳定性的影响。
Arch Oral Biol. 2009 Feb;54(2):132-7. doi: 10.1016/j.archoralbio.2008.09.007. Epub 2008 Oct 30.
10
Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference.人类肠道中的相互作用组学:乳酸杆菌和双歧杆菌发挥重要作用。
J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S163-7. doi: 10.1097/MCG.0b013e31817dbd62.